Genedrive Share Discussion Threads

[ghost_walker] 24/7/2024 21:32

Z1CO16 Jul '24 - 22:07 - 947 of 1048
0 3 1
The last delay by NICE was announced by the company at 9.28am yet a lot already knew over night and started selling at the open.

Same could happen again

[ghost_walker] 24/7/2024 21:32

Batiatus24 Jul '24 - 12:49 - 21 of 25
0 0 0
Destiny Pharma PLC

Refer to their 15 July 2024 RNS

"As previously disclosed, the Company has been seeking a licencing partner for the development of XF-73 Nasal through Phase 3 clinical trials. However, to date a deal has not been forthcoming and given our cash runway, the Board and our advisors have been evaluating a range of strategic options to access the significant quanta of funding required to progress the drug through these Phase 3 clinical trials and realise the creation of meaningful shareholder value.

"This review, and our discussions with possible funding partners, has identified that a larger pool of capital may be available to Destiny Pharma as a private company and therefore, the Board has concluded that delisting from AIM and re-registering as a private company is a necessary step to provide Destiny Pharma with a realistic chance of securing the capital required to progress XF-73 Nasal through clinical trials and bring this important product to patients and health systems."

Back to GDR and their funding and strategy, which is no where to be seen in their current position. There is also the risk of Cheek taking the company private?

Remember he refused to comment in the last presentation when a shareholder asked.

Another risk at play? Any thoughts?

Genuinely question from me, how does the company get away with shafting shareholders like that?

[batiatus] 24/7/2024 21:24

Z1co is here 24/7. Its his job.
All he is doing is copy and pasting scripts.

[z1co] 24/7/2024 21:13

The markets that the Company is targeting are significant relative to its size. The Company estimates the global overall market opportunity of its AIHL and CYP2C19 assays is over £300 million per annum.

For MT-RNR1 ID kit the company estimates that the total addressable UK market is up to £8.5 million per annum which is based on approximately 100,000 NICU admissions per annum and an estimated customer price per test of more than £80. The EU market is potentially another c.£46.75 million per annum, the U.S. market is c.£34 million and rest of World markets around £13.75 million. Market estimates are based on end user pricing.

For CYP2C19-ID Kit the Company estimates that the total addressable UK market is up to £8.5 million per annum, based on the assumption that there are over 100,000 strokes per annum and an estimated customer price per test of approximately £100. The EU market is estimated to be c.£93.5 million, the U.S. market is c.£67.6 million and rest of the world markets approximately £51 million. Market estimates are based on end user pricing.

[z1co] 24/7/2024 21:10

The markets that the Company is targeting are significant relative to its size. The Company estimates the global overall market opportunity of its AIHL and CYP2C19 assays is over £300 million per annum.

For MT-RNR1 ID kit the company estimates that the total addressable UK market is up to £8.5 million per annum which is based on approximately 100,000 NICU admissions per annum and an estimated customer price per test of more than £80. The EU market is potentially another c.£46.75 million per annum, the U.S. market is c.£34 million and rest of World markets around £13.75 million. Market estimates are based on end user pricing.

For CYP2C19-ID Kit the Company estimates that the total addressable UK market is up to £8.5 million per annum, based on the assumption that there are over 100,000 strokes per annum and an estimated customer price per test of approximately £100. The EU market is estimated to be c.£93.5 million, the U.S. market is c.£67.6 million and rest of the world markets approximately £51 million. Market estimates are based on end user pricing.

[premium beeks] 24/7/2024 21:10

Looks to be working. Good stuff.

[premium beeks] 24/7/2024 20:41

Internet update Z1co?

[genghis_khan_] 24/7/2024 20:20

Money raised with PH won't last long

possibly delisting.

Batiatus24 Jul '24 - 12:49 - 21 of 25
0 0 0
Destiny Pharma PLC

Refer to their 15 July 2024 RNS

"As previously disclosed, the Company has been seeking a licencing partner for the development of XF-73 Nasal through Phase 3 clinical trials. However, to date a deal has not been forthcoming and given our cash runway, the Board and our advisors have been evaluating a range of strategic options to access the significant quanta of funding required to progress the drug through these Phase 3 clinical trials and realise the creation of meaningful shareholder value.

"This review, and our discussions with possible funding partners, has identified that a larger pool of capital may be available to Destiny Pharma as a private company and therefore, the Board has concluded that delisting from AIM and re-registering as a private company is a necessary step to provide Destiny Pharma with a realistic chance of securing the capital required to progress XF-73 Nasal through clinical trials and bring this important product to patients and health systems."

Back to GDR and their funding and strategy, which is no where to be seen in their current position. There is also the risk of Cheek taking the company private?

Remember he refused to comment in the last presentation when a shareholder asked.

Another risk at play? Any thoughts?

Genuinely question from me, how does the company get away with shafting shareholders like that?

[genghis_khan_] 24/7/2024 20:19

Batiatus24 Jul '24 - 12:49 - 21 of 25
0 0 0
Destiny Pharma PLC

Refer to their 15 July 2024 RNS

"As previously disclosed, the Company has been seeking a licencing partner for the development of XF-73 Nasal through Phase 3 clinical trials. However, to date a deal has not been forthcoming and given our cash runway, the Board and our advisors have been evaluating a range of strategic options to access the significant quanta of funding required to progress the drug through these Phase 3 clinical trials and realise the creation of meaningful shareholder value.

"This review, and our discussions with possible funding partners, has identified that a larger pool of capital may be available to Destiny Pharma as a private company and therefore, the Board has concluded that delisting from AIM and re-registering as a private company is a necessary step to provide Destiny Pharma with a realistic chance of securing the capital required to progress XF-73 Nasal through clinical trials and bring this important product to patients and health systems."

Back to GDR and their funding and strategy, which is no where to be seen in their current position. There is also the risk of Cheek taking the company private?

Remember he refused to comment in the last presentation when a shareholder asked.

Another risk at play? Any thoughts?

Genuinely question from me, how does the company get away with shafting shareholders like that?

[socionomics] 24/7/2024 19:44

Our thoughts on the relevance of rapid point of care testing and the role it might play in a future pharmacogenomic service.

We reflect on our work with genedrive delivering the PALOH study at the Manchester University NHS Foundation Trust, which aimed to implement rapid genetic testing in newborns to avoid hearing loss.

We highlight the main findings from the study and stress the importance of maintaining stakeholder engagement as we move from research to broader implementation.

[ghost_walker] 24/7/2024 19:38

The rapist is working overtime again for £50. A bearded child from Kabul needs to feed his family of 20.

He's trying to drown threads with his posts.



Z1CO16 Jul '24 - 22:07 - 947 of 1048
0 3 1
The last delay by NICE was announced by the company at 9.28am yet a lot already knew over night and started selling at the open.

Same could happen again

[z1co] 24/7/2024 19:35

Since yesterday and today you have posted 7 times , that's well above your daily/weekly average.

LOLOL

just sayin' like

[z1co] 24/7/2024 19:29

What a pair of comedians.

Counting others posts hahahahah

Well in that case Minja19 you have posted only 536 posts since 2013 LOLOL

In all those years you only have 2 measly posters that follow you because no one is interested in what you have to say!!!

That's only one post every week so obviously just a little trader/investor.

WELL I'M SURE EVERYONE WILL BE IMPRESSED BY YOUR PROFILE.

Hope you're now happy!

I'm a full time trader hence post more than most.

[premium beeks] 24/7/2024 19:11

Can we PLEASE keep this on topic?There are other threads to post garbage on.

[z1co] 24/7/2024 19:04

Peters above post is obviously NOT very useful so why post ???

[petersinthemarket] 24/7/2024 18:50

Minja
Point absolutely taken.
But Zico (and others) filtered long ago.

Simple message.
Nothing useful to say - then say nothing.

May not suit advfn, who want volume.
But suits many contributors.
pete